Know Cancer

or
forgot password
  • cancer clinical trials in little rock, AR

  • STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    Univ Of Arkansas/Arkansas Research Center
    Little Rock, Arkansas 72205-7101
    Melanoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain Tumor, Central Nervous System Tumor
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Arkansas Oncology Associates, PA
    Little Rock, Arkansas 72207
    Non-Small Cell Lung Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Cervical Cancer
    Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
    Bressnick Gibson Parker Dinehart Sangster Dermatology, P.A.
    Little Rock, Arkansas 72205
    Psoriatic Arthritis
    Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Little Rock Hematology Oncology Associates
    Little Rock, Arkansas 72205
    Lung Cancer, Non-small-cell Lung Carcinoma
    Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Multiple Myeloma
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Esophageal Cancer
    S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
    ImClone Investigational Site
    Little Rock, Arkansas 72205
    Non-small Cell Lung Cancer
    A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

    Little Rock, Arkansas 72205-7199
    Breast Neoplasms
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain and Central Nervous System Tumors
    Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Constipation, Bowel Dysfunction
    SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Thrombocytopenia, Thrombocytopaenia
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Arkansas Oncology Associates
    Little Rock Hematology Oncology
    Ovarian Neoplasms
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Myeloma Institute For Research Therapy
    Little Rock, Arkansas 72205
    Multiple Myeloma
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Brain and Central Nervous System Tumors
    DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
    University of Arkansas for Medical Sciences/MIRT
    Little Rock, Arkansas 72205
    Waldenstrom Macroglobulinemia
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Esophageal Cancer
    S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma, Plasmacytoma
    Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    University of Arkansas, Arkansas Cancer Research Center
    Little Rock, Arkansas 72205
    Lung Cancer, Non Small Cell Lung Carcinoma
    Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy
    Multiple Myeloma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Multiple Myeloma
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Arkansas Urology
    Little Rock, Arkansas 72211
    Prostate Cancer, Osteoporosis, Fractures
    Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Osteosarcoma
    Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Genital Neoplasms, Female, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Peritoneal Neoplasms
    A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
    Duramed Investigational Site
    Little Rock, Arkansas 72211
    Prostate Cancer
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Sarcoma
    Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
    Arkansas Children's Hospital, UAMS College of Medicine
    Little Rock, Arkansas 72202
    Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Myelofibrosis
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Children's Hospital of Arkansas
    Little Rock, Arkansas 72202
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    Children's Hospital of Arkansas
    Little Rock, Arkansas 72202
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Multiple Myeloma, Carcinoma, Renal Cell
    A Long-term Safety Study of Infliximab (Remicade)

    Little Rock, Arkansas 72205-7199
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Recurrent Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell, Neoplasms, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Head and Neck Cancer
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Histamine Pharmacogenetics in Children With Atopic Dermatitis
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Dermatitis, Atopic
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Little Rock Hematology Oncology Associates
    Little Rock, Arkansas 72205
    Breast Neoplasms, Neoplasm Metastasis
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Recurrent Melanoma, Stage IV Melanoma
    Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Hepatocellular Carcinoma
    Study of ZIO-101 in Multiple Myeloma

    Little Rock, Arkansas 72205-7199
    Multiple Myeloma
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma